Meritage Portfolio Management’s Crocs CROX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-5,324
Closed -$565K 328
2025
Q1
$565K Sell
5,324
-392
-7% -$40.6K 0.04% 230
2024
Q4
$626K Sell
5,716
-2,952
-34% -$343K 0.04% 235
2024
Q3
$1.25M Buy
8,668
+902
+12% +$123K 0.08% 188
2024
Q2
$1.13M Buy
7,766
+1,375
+22% +$193K 0.07% 192
2024
Q1
$919K Sell
6,391
-603
-9% -$68.7K 0.06% 202
2023
Q4
$653K Buy
6,994
+2,297
+49% +$212K 0.04% 228
2023
Q3
$414K Buy
4,697
+2,644
+129% +$272K 0.03% 255
2023
Q2
$231K Buy
+2,053
New +$245K 0.02% 319
2022
Q1
Sell
-124,803
Closed -$16M 344
2021
Q4
$16M Sell
124,803
-7,752
-6% -$1.19M 0.91% 23
2021
Q3
$19M Buy
+132,555
New +$18.2M 1.14% 18

Other funds holding CROX

Meritage Portfolio Management's CROX Position: Q2 2025 in Review

Meritage Portfolio Management sold out of Crocs (CROX) in Q2 2025, closing a stake of 5,324 shares — an estimated $565K sold.

Meritage Portfolio Management first reported a position in CROX in Q3 2021 and held it in 10 quarters. The position peaked at $19M in Q3 2021. 506 funds tracked by Wall St. Rank hold CROX as of Q2 2025.

  • Meritage Portfolio Management reported no remaining Crocs position as of Q2 2025 after selling out during the quarter.
  • Meritage Portfolio Management sold 5,324 Crocs shares in Q2 2025, an estimated $565K.
  • Meritage Portfolio Management first reported a position in Crocs in Q3 2021 and held it in 10 quarters.
  • Meritage Portfolio Management's Crocs position peaked at $19M in Q3 2021.
  • 506 funds tracked by Wall St. Rank held Crocs as of Q2 2025.

Based on Meritage Portfolio Management's 13F filing for Q2 2025, filed 25 Jul 2025.